{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:44:11Z","timestamp":1775119451561,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recall by genotype (RbG) studies aim to better understand the phenotypes that correspond to genetic variants of interest, by recruiting carriers of such variants for further phenotyping. RbG approaches pose major ethical and legal challenges related to the disclosure of possibly unwanted genetic information. The Cooperative Health Research in South Tyrol (CHRIS) study is a longitudinal cohort study based in South Tyrol, Italy. Demand has grown for CHRIS study participants to be enrolled in RbG studies, thus making the design of a suitable ethical framework a pressing need. We here report upon the design of a pilot RbG study conducted with CHRIS study participants. By reviewing the literature and by consulting relevant stakeholders (CHRIS participants, clinical geneticists, ethics board, GPs), we identified key ethical issues in RbG approaches (e.g. complexity of the context, communication of genetic results, measures to further protect participants). The design of the pilot was based on a feasibility assessment, the selection of a suitable test case within the ProtectMove Research Unit on reduced penetrance of hereditary movement disorders, and the development of appropriate recruitment and communication strategies. An empirical study was embedded in the pilot study with the aim of understanding participants\u2019 views on RbG. Our experience with the pilot study in CHRIS allowed us to contribute to the development of best practices and policies for RbG studies by drawing recommendations: addressing the possibility of RbG in the original consent, implementing tailored communication strategies, engaging stakeholders, designing embedded empirical studies, and sharing research experiences and methodology.<\/jats:p>","DOI":"10.1038\/s41431-021-00860-7","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T03:41:41Z","timestamp":1620877301000},"page":"1146-1157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Balancing scientific interests and the rights of participants in designing a recall by genotype study"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-1464","authenticated-orcid":false,"given":"Deborah","family":"Mascalzoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Biasiotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-5986","authenticated-orcid":false,"given":"Max","family":"Borsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"De Grandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Goegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-5683","authenticated-orcid":false,"given":"Sara","family":"Frygner-Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"K\u00f6sters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3185-440X","authenticated-orcid":false,"given":"Ciara","family":"Staunton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9831-8302","authenticated-orcid":false,"given":"Peter P.","family":"Pramstaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Krawczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-0411","authenticated-orcid":false,"given":"Andrew A.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"860_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03109-y","volume":"9","author":"LJ Corbin","year":"2018","unstructured":"Corbin LJ, Tan VY, Hughes DA, Wade KH, Paul DS, Tansey KE, et al. Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference. Nat Commun. 2018;9:711.","journal-title":"Nat Commun."},{"key":"860_CR2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00439-012-1177-z","volume":"131","author":"LM Beskow","year":"2012","unstructured":"Beskow LM, Fullerton SM, Namey EE, Nelson DK, Davis AM, Wilfond BS. Recommendations for ethical approaches to genotype-driven research recruitment. Hum Genet. 2012;131:1423\u201331.","journal-title":"Hum Genet."},{"key":"860_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1101\/gr.104455.109","volume":"20","author":"LM Beskow","year":"2010","unstructured":"Beskow LM, Linney KN, Radtke RA, Heinzen EL, Goldstein DB. Ethical challenges in genotype-driven research recruitment. Genome Res. 2010;20:705\u20139.","journal-title":"Genome Res."},{"key":"860_CR4","unstructured":"Garante per la protezione dei dati personali. General authorisation no. 8\/2014 for the processing of genetic data. Garante per la protezione dei dati personali; 2014. https:\/\/www.garanteprivacy.it\/web\/guest\/home\/docweb\/-\/docweb-display\/docweb\/3831387. Accessed 14 Dec 2020."},{"key":"860_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/15265161.2017.1284920","volume":"17","author":"S Doernberg","year":"2017","unstructured":"Doernberg S, Hull SC. Harms of deception in FMR1 premutation genotype-driven recruitment. Am J Bioeth. 2017;17:62\u20133.","journal-title":"Am J Bioeth."},{"key":"860_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/15265161.2017.1284916","volume":"17","author":"LM Beskow","year":"2017","unstructured":"Beskow LM. Genotype-driven recruitment and the disclosure of individual research results. Am J Bioeth. 2017;17:64\u20135.","journal-title":"Am J Bioeth."},{"key":"860_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/15265161.2017.1284935","volume":"17","author":"HA Taylor","year":"2017","unstructured":"Taylor HA, Morales C, Wilfond BS. Genotype-driven recruitment in population-based biomedical research. Am J Bioeth. 2017;17:58\u20139.","journal-title":"Am J Bioeth."},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2217\/pme.14.89","volume":"12","author":"LM Amendola","year":"2015","unstructured":"Amendola LM, Lautenbach D, Scollon S, Bernhardt B, Biswas S, East K, et al. Illustrative case studies in the return of exome and genome sequencing results. Pers Med. 2015;12:283\u201395.","journal-title":"Pers Med."},{"key":"860_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0618-0","volume":"12","author":"T Papaz","year":"2019","unstructured":"Papaz T, Liston E, Zahavich L, Stavropoulos DJ, Jobling RK, Kim RH, et al. Return of genetic and genomic research findings: experience of a pediatric biorepository. BMC Med Genom. 2019;12:173.","journal-title":"BMC Med Genom."},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/bmb\/ldy008","volume":"126","author":"C Patch","year":"2018","unstructured":"Patch C, Middleton A. Genetic counselling in the era of genomic medicine. Br Med Bull. 2018;126:27\u201336.","journal-title":"Br Med Bull."},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41431-018-0311-3","volume":"27","author":"A Thorogood","year":"2019","unstructured":"Thorogood A, Dalpe G, Knoppers BM. Return of individual genomic research results: are laws and policies keeping step? Eur J Hum Genet. 2019;27:535\u201346.","journal-title":"Eur J Hum Genet."},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1525\/jer.2013.8.4.42","volume":"8","author":"JO Robinson","year":"2013","unstructured":"Robinson JO, Slashinski MJ, Wang T, Hilsenbeck SG, McGuire AL. Participants\u2019 recall and understanding of genomic research and large-scale data sharing. J Empir Res Hum Res Ethics. 2013;8:42\u201352.","journal-title":"J Empir Res Hum Res Ethics."},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"e44050","DOI":"10.1371\/journal.pone.0044050","volume":"7","author":"LM Beskow","year":"2012","unstructured":"Beskow LM, Check DK, Namey EE, Dame LA, Lin L, Cooper A, et al. Institutional review boards\u2019 use and understanding of certificates of confidentiality. PLoS ONE. 2012;7:e44050.","journal-title":"PLoS ONE."},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00125-005-0044-z","volume":"49","author":"GD Tan","year":"2006","unstructured":"Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis L, et al. The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia. 2006;49:158\u201368.","journal-title":"Diabetologia."},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"e0202502","DOI":"10.1371\/journal.pone.0202502","volume":"13","author":"JT Minion","year":"2018","unstructured":"Minion JT, Butcher F, Timpson N, Murtagh MJ. The ethics conundrum in Recall by Genotype (RbG) research: perspectives from birth cohort participants. PLoS ONE. 2018;13:e0202502.","journal-title":"PLoS ONE."},{"key":"860_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-6-19","volume":"6","author":"I Budin-Ljosne","year":"2013","unstructured":"Budin-Ljosne I, Soye KJ, Tasse AM, Knoppers BM, Harris JR. Genotype-driven recruitment: a strategy whose time has come? BMC Med Genom. 2013;6:19.","journal-title":"BMC Med Genom."},{"key":"860_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0704-9","volume":"13","author":"C Pattaro","year":"2015","unstructured":"Pattaro C, Gogele M, Mascalzoni D, Melotti R, Schwienbacher C, De Grandi A, et al. The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results. J Transl Med. 2015;13:348.","journal-title":"J Transl Med."},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrg3218","volume":"13","author":"J Kaye","year":"2012","unstructured":"Kaye J, Curren L, Anderson N, Edwards K, Fullerton SM, Kanellopoulou N, et al. From patients to partners: participant-centric initiatives in biomedical research. Nat Rev Genet. 2012;13:371\u20136.","journal-title":"Nat Rev Genet."},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/gim.2012.88","volume":"14","author":"M Michie","year":"2012","unstructured":"Michie M, Cadigan RJ, Henderson G, Beskow LM. Am I a control?: genotype-driven research recruitment and self-understandings of study participants. Genet Med. 2012;14:983\u20139.","journal-title":"Genet Med"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1525\/jer.2011.6.4.41","volume":"6","author":"HK Tabor","year":"2011","unstructured":"Tabor HK, Brazg T, Crouch J, Namey EE, Fullerton SM, Beskow LM, et al. Parent perspectives on pediatric genetic research and implications for genotype-driven research recruitment. J Empir Res Hum Res Ethics. 2011;6:41\u201352.","journal-title":"J Empir Res Hum Res Ethics."},{"key":"860_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1525\/jer.2011.6.4.3","volume":"6","author":"LM Beskow","year":"2011","unstructured":"Beskow LM, Namey EE, Cadigan RJ, Brazg T, Crouch J, Henderson GE, et al. Research participants\u2019 perspectives on genotype-driven research recruitment. J Empir Res Hum Res Ethics. 2011;6:3\u201320.","journal-title":"J Empir Res Hum Res Ethics."},{"key":"860_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1525\/jer.2011.6.4.30","volume":"6","author":"RJ Cadigan","year":"2011","unstructured":"Cadigan RJ, Michie M, Henderson G, Davis AM, Beskow LM. The meaning of genetic research results: reflections from individuals with and without a known genetic disorder. J Empir Res Hum Res Ethics. 2011;6:30\u201340.","journal-title":"J Empir Res Hum Res Ethics."},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1525\/jer.2011.6.4.21","volume":"6","author":"EE Namey","year":"2011","unstructured":"Namey EE, Beskow LM. Epilepsy patient-participants and genetic research results as \u201canswers\u201d. J Empir Res Hum Res Ethics. 2011;6:21\u20139.","journal-title":"J Empir Res Hum Res Ethics."},{"key":"860_CR24","first-page":"1","volume":"34","author":"LM Beskow","year":"2012","unstructured":"Beskow LM, Namey EE, Miller PR, Nelson DK, Cooper A. IRB chairs\u2019 perspectives on genotype-driven research recruitment. IRB. 2012;34:1\u201310.","journal-title":"IRB."},{"key":"860_CR25","doi-asserted-by":"publisher","first-page":"e1007458","DOI":"10.1371\/journal.pgen.1007458","volume":"14","author":"AC Richard","year":"2018","unstructured":"Richard AC, Peters JE, Savinykh N, Lee JC, Hawley ET, Meylan F, et al. Reduced monocyte and macrophage TNFSF15\/TL1A expression is associated with susceptibility to inflammatory bowel disease. PLoS Genet. 2018;14:e1007458.","journal-title":"PLoS Genet."},{"key":"860_CR26","doi-asserted-by":"publisher","unstructured":"Stacey D, Chen L, Howson JM, Mason AM, Burgess S, MacDonald S, et al. Elucidating mechanisms of genetic cross-disease associations: an integrative approach implicates protein C as a causal pathway in arterial and venous diseases. 2020. https:\/\/doi.org\/10.1101\/2020.03.16.20036822.","DOI":"10.1101\/2020.03.16.20036822"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/schbul\/sby037","volume":"45","author":"TM Lancaster","year":"2019","unstructured":"Lancaster TM, Dimitriadis SL, Tansey KE, Perry G, Ihssen N, Jones DK, et al. Structural and functional neuroimaging of polygenic risk for schizophrenia: a recall-by-genotype-based approach. Schizophr Bull. 2019;45:405\u201314.","journal-title":"Schizophr Bull."},{"key":"860_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-020-01689-9","volume":"16","author":"LJ Corbin","year":"2020","unstructured":"Corbin LJ, Hughes DA, Chetwynd AJ, Taylor AE, Southam AD, Jankevics A, et al. Metabolic characterisation of disturbances in the APOC3\/triglyceride-rich lipoprotein pathway through sample-based recall by genotype. Metabolomics. 2020;16:69.","journal-title":"Metabolomics."},{"key":"860_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mce.2016.03.020","volume":"428","author":"BP Lee","year":"2016","unstructured":"Lee BP, Lloyd-Laney HO, Locke JM, McCulloch LJ, Knight B, Yaghootkar H, et al. Functional characterisation of ADIPOQ variants using individuals recruited by genotype. Mol Cell Endocrinol. 2016;428:49\u201357.","journal-title":"Mol Cell Endocrinol."},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41436-018-0311-2","volume":"21","author":"M Alver","year":"2019","unstructured":"Alver M, Palover M, Saar A, Lall K, Zekavat SM, Tonisson N, et al. Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia. Genet Med. 2019;21:1173\u201380.","journal-title":"Genet Med."},{"key":"860_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cmet.2016.04.009","volume":"23","author":"T Tuomi","year":"2016","unstructured":"Tuomi T, Nagorny CLF, Singh P, Bennet H, Yu Q, Alenkvist I, et al. Increased melatonin signaling is a risk factor for type 2 diabetes. Cell Metab. 2016;23:1067\u201377.","journal-title":"Cell Metab."},{"key":"860_CR32","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.euroneuro.2016.05.007","volume":"26","author":"MJ Geiger","year":"2016","unstructured":"Geiger MJ, Domschke K, Homola GA, Schulz SM, Nowak J, Akhrif A, et al. ADORA2A genotype modulates interoceptive and exteroceptive processing in a fronto-insular network. Eur Neuropsychopharmacol. 2016;26:1274\u201385.","journal-title":"Eur Neuropsychopharmacol."},{"key":"860_CR33","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1042\/CS20160433","volume":"130","author":"I Oliva","year":"2016","unstructured":"Oliva I, Guardiola M, Vallve JC, Ibarretxe D, Plana N, Masana L, et al. APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels. Clin Sci. 2016;130:2053\u20139.","journal-title":"Clin Sci."},{"key":"860_CR34","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.117.033278","volume":"138","author":"KH Wade","year":"2018","unstructured":"Wade KH, Chiesa ST, Hughes AD, Chaturvedi N, Charakida M, Rapala A, et al. Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses. Circulation. 2018;138:2187\u2013201.","journal-title":"Circulation."},{"key":"860_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-13","volume":"15","author":"JJ Ware","year":"2014","unstructured":"Ware JJ, Timpson N, Davey Smith G, Munafo MR. A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol. BMC Med Genet. 2014;15:13.","journal-title":"BMC Med Genet."},{"key":"860_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0244-4","volume":"16","author":"C Hellmich","year":"2015","unstructured":"Hellmich C, Durant C, Jones MW, Timpson NJ, Bartsch U, Corbin LJ. Genetics, sleep and memory: a recall-by-genotype study of ZNF804A variants and sleep neurophysiology. BMC Med Genet. 2015;16:96.","journal-title":"BMC Med Genet."},{"key":"860_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41588-017-0005-8","volume":"50","author":"J Schwartzentruber","year":"2018","unstructured":"Schwartzentruber J, Foskolou S, Kilpinen H, Rodrigues J, Alasoo K, Knights AJ, et al. Molecular and functional variation in iPSC-derived sensory neurons. Nat Genet. 2018;50:54\u201361.","journal-title":"Nat Genet."},{"key":"860_CR38","unstructured":"CHRIS Team. Studio sulla salute in Alto Adige. Informazioni sullo studio. CHRIS Team; 2019. https:\/\/it.chris.eurac.edu\/wp-content\/uploads\/sites\/11\/2020\/04\/03-25-CHRIS-brochure-IT_2020-002-1.pdf. Accessed 2 Oct 2020."},{"key":"860_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature."},{"key":"860_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","volume":"78","author":"M Anheim","year":"2012","unstructured":"Anheim M, Elbaz A, Lesage S, Durr A, Condroyer C, Viallet F, et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology. 2012;78:417\u201320.","journal-title":"Neurology."},{"key":"860_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","volume":"6","author":"C Klein","year":"2007","unstructured":"Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol. 2007;6:652\u201362.","journal-title":"Lancet Neurol."},{"key":"860_CR42","doi-asserted-by":"publisher","unstructured":"Lubbe SJ, Bustos B, Hu J, Krainc D, Joseph T, Hehir J, et al. Assessing the relationship between monoallelic PARK2 mutations and Parkinson\u2019s risk. 2020. https:\/\/doi.org\/10.1101\/2020.06.26.20138172.","DOI":"10.1101\/2020.06.26.20138172"},{"key":"860_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.parkreldis.2008.11.014","volume":"15","author":"N Bruggemann","year":"2009","unstructured":"Bruggemann N, Mitterer M, Lanthaler AJ, Djarmati A, Hagenah J, Wiegers K, et al. Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers. Parkinsonism Relat Disord. 2009;15:425\u20139.","journal-title":"Parkinsonism Relat Disord."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-021-00860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-021-00860-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-021-00860-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:33Z","timestamp":1684616553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00860-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1038\/s41431-021-00860-7","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CK serves as a medical advisor for Centogene for genetic testing reports in the field of movement disorders and dementia, excluding Parkinson\u2019s disease. The other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}